Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement
Physician's Weekly
JULY 1, 2025
Several authors disclosed ties to relevant organizations, including Eli Lilly, the manufacturer of tirzepatide. Bruno Linetzky, M.D., The researchers found that participants who lost at least 35 percent of their body weight from baseline to week 72 had mean changes of up to –14.2 cm for waist circumference, –59.7 All rights reserved.
52 
Let's personalize your content